{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Pretreatment of rats with sodium salicylate , ED50 103 mg / kg ( 60 - 174 ) , and phenylbutazone , 59 mg / kg ( 50 - 70 ) converted the non - convulsant dose of pilocarpine , 200 mg / kg , to a convulsant one .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the given paragraph |\n\nThe paragraph is discussing the effect of certain drugs on pilocarpine, but it does not mention any specific diseases."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the given paragraph |\n\nThe paragraph is discussing the effect of drugs on pilocarpine, but it does not mention any specific diseases. The drugs mentioned are sodium salicylate, phenylbutazone, and pilocarpine, but they are not diseases."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Pretreatment of rats with sodium salicylate , ED50 103 mg / kg ( 60 - 174 ) , and phenylbutazone , 59 mg / kg ( 50 - 70 ) converted the non - convulsant dose of pilocarpine , 200 mg / kg , to a convulsant one .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| sodium salicylate |\n| ED50 of sodium salicylate (103 mg / kg) |\n| range of ED50 of sodium salicylate (60 - 174 mg / kg) |\n| phenylbutazone |\n| ED50 of phenylbutazone (59 mg / kg) |\n| range of ED50 of phenylbutazone (50 - 70 mg / kg) |\n| pilocarpine |\n| non-convulsant dose of pilocarpine (200 mg / kg) |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| sodium salicylate |\n| ED50 of sodium salicylate (103 mg / kg) |\n| phenylbutazone |\n| ED50 of phenylbutazone (59 mg / kg) |\n| pilocarpine |\n| non-convulsant dose of pilocarpine (200 mg / kg) |\n\nThese are the entities in the paragraph that can be clearly identified as chemicals. The numbers in parentheses are quantifiers and are included as part of the chemical entities. The terms \"ED50\" and \"dose\" are also included as part of the chemical entities, as they are directly related to the specific chemicals mentioned."}
  ]
}